Entourage Health Q1 Revenue Declines 4.8% YoY, What About Adjusted EBITDA?
Portfolio Pulse from Vuk Zdinjak
Entourage Health Corp. reported Q1 2023 net revenue of CA$11.8 million, a 4.8% decrease YoY. Gross profit increased to CA$4.0 million, while adjusted EBITDA was negative CA$3.4 million. The company's medical stream grew by 61% and pre-roll sales in the adult-use segment increased, capturing 5% of the market.
May 30, 2023 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Entourage Health's Q1 2023 revenue declined 4.8% YoY, but the company saw growth in its medical stream and pre-roll sales. Adjusted EBITDA was negative CA$3.4 million.
Entourage Health's Q1 2023 revenue decline may negatively impact the stock price, but the growth in medical stream and pre-roll sales could offset this. The negative adjusted EBITDA may also be a concern for investors, but the company's strategic initiatives and cost improvements could lead to future profitability.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100